MedDataX Logo

The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery

NCT ID: NCT05647642

Last Updated: 2022-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-16

Study Completion Date

2023-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer surgery. The STAI-1(State Trait Anxiety İnventory ) form and APAIS (Amsterdam Preoperative Anxiety and İnformation Scale) scale were filled in for all preoperative patients. Afterwards, the patients were treated with either midazolam or dexmedetothymidine, depending on the anesthesiologist's preference. After administration, he was taken to surgery. As intraoperative analgesics, 2 mg/kg tramadol and 15 mg/kg paracetamol were administered to all patients. postoperative recovery time (aldrete 10), 1., 2.,6.,12.,24. VAS score, postoperative nausea-vomiting scale, STAI-1(State Trait Anxiety İnventory ) form, first need time if postoperative analgesic was needed, and 24-hour total analgesic consumption were recorded. It was aimed to examine the effects of different premedications on postoperative pain and anxiety

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low dose midazolam

0,025 mg/kg Midazolam

Precedex and dormicum

Intervention Type DRUG

Premedication

high dose midazolam

0,05 mg/kg Midazolam

Precedex and dormicum

Intervention Type DRUG

Premedication

low dose dexmedetothymidine

0.5 mg/kg dexmedetothymidine 10 minute infusion

Precedex and dormicum

Intervention Type DRUG

Premedication

high dose dexmedetothymidine

1mg/kg dexmedetothymidine 10 minute infusion

Precedex and dormicum

Intervention Type DRUG

Premedication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Precedex and dormicum

Premedication

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA 1-2-3
* 18-65 aged
* Female patients

Exclusion Criteria

* Under 18 years old and over 65 years old
* Having a history of cerebrovascular disease illiteracy
* Have visual and auditory problems İnability to cooperate with cognitive function test
* Having emergency surgery
* Those who are unable to read, understand and sign the consent form
* Patients deemed unsuitable by the investigator
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seyda ARI

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AbdurrahmanYAOTRH

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Seyda ARİ

Role: CONTACT

Phone: +905382598442

Email: [email protected]

Guldeniz ARGUN

Role: CONTACT

Phone: +905336230405

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Abdurrahman Yurtaslan Onkoloji Training and Research Hospital

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-09/2057

Identifier Type: -

Identifier Source: org_study_id